Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 1/20 | 1.00 |
| ▸ | CASP6 | P55212 | 1/20 | 0.70 |
| ▸ | TSHR | P16473 | 3/20 | 0.64 |
| ▸ | HCAR3 | P49019 | 7/20 | 0.58 |
| ▸ | TDP1 | Q9NUW8 | 4/20 | 0.58 |
| ▸ | MEN1 | O00255 | 2/20 | 0.58 |
| ▸ | MAPT | P10636 | 2/20 | 0.58 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.58 |
| ▸ | POLB | P06746 | 1/20 | 0.58 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.58 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.58 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.58 |
| ▸ | APEX1 | P27695 | 1/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1162258 | 1.00 | LMNA (1.00) | LMNACASP6TSHRHCAR3TDP1 | |
| SCHEMBL3392676 | 0.93 | LMNA (0.87) | LMNACASP6TSHRHCAR3TDP1 | |
| 1,5-Pentanediol SCHEMBL8846459 | 0.89 | LMNA (0.79) | LMNACASP6TSHRHCAR3TDP1 | |
| SCHEMBL31174170 | 0.87 | LMNA (0.77) | LMNACASP6TSHRTDP1MEN1 | |
| SCHEMBL865520 | 0.87 | LMNA (0.77) | LMNACASP6TSHRTDP1MEN1 | |
| SCHEMBL1607853 | 0.85 | LMNA (0.74) | LMNACASP6TSHRHCAR3TDP1 | |
| SCHEMBL1470130 | 0.85 | LMNA (0.74) | LMNACASP6TSHRTDP1MEN1 | |
| SCHEMBL10532614 | 0.84 | LMNA (0.71) | LMNAHCAR3MEN1MAPTKMT2A | |
| SCHEMBL27717235 | 0.84 | LMNA (0.71) | LMNACASP6TSHRHCAR3TDP1 | |
| SCHEMBL263311 | 0.84 | LMNA (0.72) | LMNATSHRTDP1MEN1MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1116 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118880486-B | Cool polyester fiber and preparation method thereof | 江苏恒科新材料有限公司 | 2025-06-24 | — | — | CN | claimed |
| CN-120114456-A | Pyruvate-based composition for treating pneumonia and preparation method thereof | 江苏长泰药业股份有限公司 | 2025-06-10 | — | — | CN | claimed |
| CN-115584102-B | Creep-resistant insulating engineering plastic and preparation method thereof | 丁克锋 | 2024-11-15 | — | — | CN | claimed |
| CN-118880486-A | Cool polyester fiber and preparation method thereof | 江苏恒科新材料有限公司 | 2024-11-01 | — | — | CN | claimed |
| CN-118440680-B | Corrosion inhibitor for high-temperature-resistant acidification and preparation method thereof | 寿光新海能源技术有限公司 | 2024-10-22 | — | — | CN | claimed |
| CN-118440680-A | Corrosion inhibitor for high-temperature-resistant acidification and preparation method thereof | 寿光新海能源技术有限公司 | 2024-08-06 | — | — | CN | claimed |
| CN-118405988-A | Novel ferrostatin-1 analogue, preparation method and application | 大连理工大学 | 2024-07-30 | — | — | CN | claimed |
| CN-114080383-B | Process for preparing indole or indazole compounds | 株式会社LG化学 | 2024-07-23 | — | — | CN | claimed |
| CN-118359893-A | Preparation method of creep-resistant insulating engineering plastic | 丁克锋 | 2024-07-19 | — | — | CN | claimed |
| CN-117164855-A | High-cohesiveness branched polyimide polymer and preparation method thereof | 江苏环峰电工材料有限公司 | 2023-12-05 | — | — | CN | claimed |
| CN-1738650-A | Improved gastrin releasing peptide compounds | BRACCO IMAGING SPA (IT) | 2006-02-22 | — | — | CN | claimed |
| US-20060018830-A1 | Gastrin releasing peptide compounds | BRACCO IMAGING S.P.A. (IT) | 2006-01-26 | — | — | US | claimed |
| EP-1585549-A2 | IMPROVED GASTRIN RELEASING PEPTIDE COMPOUNDS | Bracco Imaging S.p.A. (IT) | 2005-10-19 | — | — | EP | claimed |
| US-20040253225-A1 | bombesin, derivatives and/or analogues capable of complexing metal ions, radionuclides or optical labels, for use in radiotherapy | BRACCO IMAGING S.P.A. (IT) | 2004-12-16 | — | — | US | claimed |
| WO-2004065407-A2 | IMPROVED GASTRIN RELEASING PEPTIDE COMPOUNDS | BRACCO IMAGING S.P.A. (IT) | 2004-08-05 | — | — | WO | claimed |
| US-20040136906-A1 | Gastrin releasing peptide compounds | BRACCO IMAGING S.P.A. (IT) | 2004-07-15 | — | — | US | claimed |
| WO-2002095393-A2 | DRUG EVOLUTION: DRUG DESIGN AT HOT SPOTS | NATIONAL RESEARCH COUNCIL OF CANADA (CA) | 2002-11-28 | — | — | WO | claimed |
| EP-0429614-B1 | AZOPHENYL COMPOUNDS | JAMES ROBINSON LTD (GB) | 1995-10-11 | — | — | EP | claimed |
| EP-0429614-A1 | AZOPHENYL COMPOUNDS. | JAMES ROBINSON LTD (GB) | 1991-06-05 | — | — | EP | claimed |
| WO-1990015850-A1 | AZOPHENYL COMPOUNDS | JAMES ROBINSON LIMITED (GB) | 1990-12-27 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040253225-A1 | bombesin, derivatives and/or analogues capable of complexing metal ions, radionuclides or optical labels, for use in radiotherapy | GRPR, MLNR, NPBWR1 | LMNA 1801/4885CASP6 3528/4885TSHR 160/4885 |
| US-20060018830-A1 | Gastrin releasing peptide compounds | GRPR, GIPR, CCKBR | LMNA 4181/4885CASP6 2598/4885TSHR 136/4885 |
| US-20040136906-A1 | Gastrin releasing peptide compounds | GRPR, GIPR, MLNR | LMNA 3400/4885CASP6 3785/4885TSHR 136/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.